1. |
Umetsu DT. Mechanisms by which obesity impacts upon asthma. Thorax, 2016, 72(2): 174.
|
2. |
Inomata M, Kamio K, Azuma A. Pirfenidone inhibits fibrocyte accumulation in the lungs in bleomycin-induced murine pulmonary fibrosis. Respir Res, 2014, 15(1): 1-14.
|
3. |
Wang J, Yang Y, Xu J, et al. Pirfenidone inhibits migration, differentiation, and proliferation of human retinal pigment epithelial cells in vitro. Mol Vis, 2013, 19(11): 2626-2635.
|
4. |
Hirano A, Kanehiro A, Ono K, et al. Pirfenidone modulates airway responsiveness, inflammation, and remodeling after repeated challenge. Am J Respir Cell Mol Biol, 2006, 35(3): 366-377.
|
5. |
Mansoor JK, Decile KC, Giri SN, et al. Influence of pirfenidone on airway hyperresponsiveness and inflammation in a Brown-Norway rat model of asthma. Pulm Pharmacol Ther, 2007, 20(6): 660-668.
|
6. |
Durcan PJ, Corbett JJ, Wall M. The incidence of pseudotumor cerebri: population studies in Iowa and Louisiana. JAMA Neurol, 1988, 45(8): 875-877.
|
7. |
Han W, Li J, Tang HP, et al. Treatment of obese asthma in a mouse model by simvastatin is associated with improving dyslipidemia and decreasing leptin level. Biochem Biophys Res Commun, 2017, 484(2): 396-402.
|
8. |
Chen M, Lv Z, Zhang W, et al. Triptolide suppresses airway goblet cell hyperplasia and Muc5ac expression via NF-κB in a murine model of asthma. Mol Immunol, 2015, 64(1): 99-105.
|
9. |
Dixon AE, Holguin F, Sood A, et al. An official American Thoracic Society Workshop report: obesity and asthma. Proc Am Thorac Soc, 2010, 7(5): 325-335.
|
10. |
韩伟, 陈凯, 唐华平, 等. 肥胖型哮喘小鼠体内氧化应激反应变化及其与气道炎症和重构的关系. 中国呼吸与危重监护杂志, 2011, 10(4): 331-334.
|
11. |
王丽霞, 韩伟, 陈伟, 等. 辛伐他汀对肥胖哮喘小鼠气道炎症和重构的影响. 中华实用诊断与治疗杂志, 2016, 30(5): 435-438.
|
12. |
Taguchi Y, Ebina M, Hashimoto S, et al. Efficacy of pirfenidone and disease severity of idiopathic pulmonary fibrosis: extended analysis of phase Ⅲ trial in Japan. Respir Invest, 2015, 53(6): 279-287.
|
13. |
Macías-Barragán J, Sandoval-Rodríguez A, Navarro-Partida J, et al. The multifaceted role of pirfenidone and its novel targets. Fibrogenesis Tissue Repair, 2010, 3(1): 16.
|
14. |
Schaefer CJ, Ruhrmund DW, Pan L, et al. Antifibrotic activities of pirfenidone in animal models. Eur Respir Rev, 2011, 20(120): 85-97.
|
15. |
Li XZ, Feng JC, Hu CP, et al. Effects of Arkadia on airway remodeling through enhancing TGF-β signaling in allergic rats. Lab Invest, 2010, 90(7): 997-1003.
|
16. |
Sutherland ER, Goleva E, King TS, et al. Cluster analysis of obesity and asthma phenotypes. Plos One, 2012, 7(5): e36631.
|
17. |
Bottoms SE, Howell JE, Reinhardt AK, et al. TGF-β isoform specific regulation of airway inflammation and remodelling in a murine model of asthma. Plos One, 2012, 5(3): e9674.
|
18. |
Halwani R, Al-Muhsen S, Al-Jahdali H, et al. Role of transforming growth factor-beta in airway remodeling in asthma. Am J Respir Cell Mol Biol, 2011, 44(2): 127-133.
|
19. |
Panek M, Pietras T, Fabijan A, et al. The NR3C1 glucocorticoid receptor gene polymorphisms may modulate the TGF-beta mRNA expression in asthma patients. Inflammation, 2015, 38(4): 1479.
|
20. |
Lee HY, Kim IK, Yoon HK, et al. Inhibitory effects of resveratrol on airway remodeling by transforming growth factor-β/smad signaling pathway in chronic asthma model. Allergy Asthma Immunol Res, 2017, 9(1): 25-34.
|
21. |
Jiang K, Chen HB, Wang Y, et al. Changes in interleukin-17 and transforming growth factor beta 1 levels in serum and bronchoalveolar lavage fluid and their clinical significance among children with asthma. Transl Pediatrics, 2013, 2(4): 154-159.
|
22. |
Durrani SR, Viswanathan RK, Busse WW. What effect does asthma treatment have on airway remodeling? Current perspectives. J Allergy Clin Immunol, 2011, 128(3): 439-448.
|
23. |
Takeda Y, Tsujino K, Kijima T, et al. Efficacy and safety of pirfenidone for idiopathic pulmonary fibrosis. Patient Prefer Adherence, 2014, 8(3): 61-70.
|
24. |
方丽萍, 辛晓峰. 支气管哮喘药物治疗对气道重塑的影响. 中华结核和呼吸杂志, 2012, 35(12): 927-929.
|
25. |
Hirota N, Martin JG. Mechanisms of airway remodeling. Chest, 2013, 144(3): 1026-1032.
|
26. |
Kang HS, Rhee CK, Lee HY, et al. Different anti-remodeling effect of nilotinib and fluticasone in a chronic asthma model. Korean J Intern Med, 2016, 31(6): 1150-1158.
|